FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate
Histopathology · 2026-08 · 89 (2) · 240-250
DOI: 10.1111/his.70166 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, online erschienen am 07.05.2026. Verfasst von Jianping Zhao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Hauptthemen laut MEDLINE: Hepatocyte Nuclear Factor 3-alpha, Prostatic Neoplasms, Biomarkers, Tumor, Carcinoma, Small Cell. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institutional Research Grant program at the University of Texas MD Anderson Cancer Center, Andrew Sabin Family Fellowship.
Abstract (Originalsprache)
Aims
Prostate cancer is one of the most common malignancies in men and a major cause of cancer‐related mortality worldwide. While second‐generation antiandrogens induce durable responses, they have also led to the emergence of aggressive, androgen‐independent subtypes of prostate cancer, including small cell carcinoma of the prostate. The diagnosis of these subtypes remains challenging due to the frequent loss of traditional prostatic markers, and novel prostate‐specific markers are needed in routine pathology practice. Methods and results Through analysis of the Cancer Genome Atlas (TCGA) database, we identified Forkhead box protein A1 (FOXA1) as a potential diagnostic marker for prostatic cancer. We compared FOXA1 and NKX3.1 expression in benign prostatic glands and prostatic adenocarcinoma; FOXA1 immunostaining demonstrated a similar nuclear staining pattern to NKX3.1 and a high sensitivity for prostatic adenocarcinoma. Notably, in small cell carcinoma of the prostate, which typically loses expression of traditional prostate markers, FOXA1 expression was detected in 8 of 10 (80%) primary cases and 12 of 21 (57%) metastatic cases in our cohort. We also evaluated FOXA1 expression across various tumour types and observed positivity in 25 of 44 (57%) breast carcinomas, 15 of 68 (22%) urothelial carcinomas and rarely in other tumour types. Among 106 neuroendocrine tumours/carcinomas from different organs, only 2 of 4 breast neuroendocrine carcinomas showed FOXA1 expression.
Conclusions
FOXA1 is a highly sensitive diagnostic marker for prostate cancer. It can serve as a valuable adjunct for confirming prostatic origin in diagnostically challenging cases such as prostatic small cell carcinoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anatomical Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
- Department of Pathology, The Johns Hopkins Hospital, Baltimore, Maryland, USA.
- Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
ORCID-Profile: Jianping Zhao, Jun Yao, Ezra Baraban, Ruihe Lin, Charles C Guo, Lei Huo, Wei Lu, Shufang Wang, Luisa Maren Solis Soto, Qingqing Ding
Förderung
- Institutional Research Grant program at the University of Texas MD Anderson Cancer Center
- Andrew Sabin Family Fellowship
Zitieren
APA
Zhao, J., Yao, J., Hosseini, H., Baraban, E., Lin, R., Guo, C. C., Huo, L., Lu, W., Khan, K., Wang, S., Soto, L. M. S., & Ding, Q. (2026). FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate. Histopathology, 89(2), 240-250. https://doi.org/10.1111/his.70166
Vancouver
Zhao J, Yao J, Hosseini H, Baraban E, Lin R, Guo CC, et al. FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate. Histopathology. 2026;89(2):240-250. doi:10.1111/his.70166
BibTeX
@article{Zhao2026,
author = {Zhao, Jianping and Yao, Jun and Hosseini, Hossein and Baraban, Ezra and Lin, Ruihe and Guo, Charles C and Huo, Lei and Lu, Wei and Khan, Khaja and Wang, Shufang and Soto, Luisa Maren Solis and Ding, Qingqing},
title = {FOXA1 is a highly sensitive diagnostic marker for prostate cancer including small cell carcinoma of the prostate},
journal = {Histopathology},
year = {2026},
volume = {89},
number = {2},
pages = {240--250},
doi = {10.1111/his.70166}
}
EUVIMED